Inovio Pharmaceuticals
INO
INO
105 hedge funds and large institutions have $192M invested in Inovio Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.67% more ownership
Funds ownership: 2.59% → 3.26% (+0.67%)
42% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $3.16M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
105
Holding in Top 10
–
Calls
$1.83M
Puts
$3.16M
Top Buyers
| 1 | +$7.86M | |
| 2 | +$7.39M | |
| 3 | +$4.44M | |
| 4 |
IG
ING Group
Amsterdam,
Netherlands
|
+$3.22M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.08M |
Top Sellers
| 1 | -$4.82M | |
| 2 | -$2.04M | |
| 3 | -$1.05M | |
| 4 |
BAMS
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
|
-$816K |
| 5 |
State Street
Boston,
Massachusetts
|
-$484K |